The results showed that treatment was associated with: a reduction in hyperphagia, as reflected by an average drop of 8.5 points in the Hyperphagia Questionnaire for Clinical Trials (HQ-CT) score, a caregiver-reported assessment of hyperphagia-related behaviors a trend toward decreased body fat, by about 1.5%, and increased lean muscle, by more than 2% A global Phase 3 trial dubbed HERO (NCT06828861) is now testing ARD-101, taken twice daily for about three months, against a placebo in an estimated 90 teenagers and adults with PWS
Many clinics and wellness centers offer B12 injections
Klaritys 2,000+ licensed providers offer fully online evaluations with same-day appointments
Patients face safety risks with counterfeit and compounded prescription weight-loss drugs Officials warn of counterfeit and compounding pharmacy concerns as demand for weight-loss medicines surges
AICAR prevents acute olanzapine-induced disturbances in glucose homeostasis
These combined effects help improve glycemic control and promote sustained weight reduction